Abstract -The diagnosis and incidence of spinocerebelar ataxias (SCA) is sometimes difficult to analyze due the overlap of phenotypes subtypes and are disorders of mutations caused by CAG trinucleotide repeat expansion. To investigate the incidence of the SCA in Southern Brazil, we analyzed the trinucleotide repeats (CAG)n at the SCA1, SCA2, SCA3, SCA6 and SCA7 loci to identify allele size ranges and frequencies. We examined blood sample from 154 asymptomatic blood donors and 115 individuals with progressive ataxias.
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Spinocerebellar ataxia (SCA) subtypes 1, 2, 3 (MJD), 6 (CACNA1), and 7 are late-onset disorders with an autosomal dominant pattern. SCAs are a heterogeneous group of neurodegenerative disorders with progressive deterioration in balance and coordination. The clinical diagnosis of each one of the several types is complicated by the overlap of the phenotypes between genetic subtypes. Prevalence of SCA is estimated to be 3 in 100,000 people. However, it is possible that this figure is underestimated. The prevalence of specific subtypes depends on the ethnic origin and geographic location of the populations studied 1 . The mutations associated with the SCA1, SCA2, SCA3, SCA6 and SCA7 (chromosomes 6p23, 12q23-24.1, 14q21, 19p and 3p21.2-12, respectively) subtypes are caused by CAG trinucleotide repeat expansions in the patient's genes. These expansions encode polyglutamine repeats. The number of CAG trinucleotide repeats varies from one population to another [2] [3] [4] . In normal individuals, SCA 1 alleles range from 6 to 39 CAG repeats (CAGn) [5] [6] [7] [8] ; in SCA2 alleles range from 15 to 24 CAGn [9] [10] [11] ; in SCA3 (Machado Joseph disease -MJD) from 13 to 41 CAGn [12] [13] [14] ; in SCA6¨from 6 to 16 CAGn [15] [16] , and in SCA7 ranges from 4 to 17 CAGn [17] [18] . Intermediate alleles are found in studies with families which have not been described in the normal population. Individuals that present intermediate alleles between normal and affected may not clinically manifest the disease, while other individuals with the same allele may show signs and symptoms, and can be considered to have alleles with reduced penetrance. The presence of these three distinct groups of alleles shows the importance of defining the range of CAG repetitions for normal individuals and patients for each population 19 . Population genetic analysis of expansion diseases suggests a controversial pathogenic mechanism among them [20] [21] [22] [23] . There is the hypothesis that most cases of new mutations that cause expansion diseases arise from the existence of a large number of normal repetitions or intermediate alleles in the non-affected population. These alleles have been considered reservoirs for the generation of new expanded alleles 24 . The ability to correlate the prevalence of a particular expansion disease with the frequency of highest size of normal alleles in the respective gene depends directly on the epidemiological profile of these diseases. This correlation was no observed among Portuguese with MJD and no intermediate alleles were seen in the normal population 23 . Moreover, it is believed that expanded alleles in MJD are maintained in the population over generations by presenting greater adaptive value 25 . Allelic frequencies in the normal population could explain the evolutionary mechanism to support expanded alleles through generations 20, 23 . The present study is an analysis of trinucleotide (CAG) n repeats in unaffected and affected individuals from Southern Brazil (Paraná) of SCA1, SCA2, SCA3, SCA6 or SCA7 ataxia in order to define protocols, allelic frequency and repeat number ranges (number of CAG repeats).
METHOD

DNA samples
The sample consisted of 154 asymptomatic blood donors from Southern Brazil (Paraná) chosen at random and 115 patients with progressive ataxia after being ruled out structural disorder of the central nervous system. The suspicion diagnosis according the clinical findings were SCA2 (7 cases), SCA3 (30 cases), SCA4 (1 case), SCA6 (5 cases), SCA7 (3 cases), SCA8 (1 case), SCA10 (7 cases), Friedreich ataxia (2 cases) and unclassified ataxias by clinical findings (59 cases). None of the blood donors included in this sample had a clinical diagnosis or family history of spinocerebellar ataxia. The donor group consisted of 90 males and 64 females, with a mean age of 32.29±10.63 years. The population breakdown of the blood donor group was as follows: 72.46% Euro-Brazilians, 2.17 % Afro-Brazilians, 23.19 % admixed and 2.17% Amerindians.
Blood samples were collected in tubes with EDTA (BD Vacutainer), and genomic DNA was extracted from peripheral leukocytes using a phenol-chloroform procedure as previously described 26 . Written informed consent was obtained from each individual. The study had been previously approved by the Ethics Committee of the Hospital de Clínicas -Universidade Federal do Paraná.
PCR amplification and capillary electrophoresis
The five loci were amplified in three different reactions with 10 to 30 ng of genomic DNA using an MJ Research model PTC thermal cycler (MJ Research, inc., Watertown, MA, USA). Primers were end-labeled with fluorescent dyes appropriate for ABI PRISM instruments (Applied Biosystems, Foster City, CA, USA). Fluorescent labels were selected based on the normal allele size ranges described above for each locus, while taking care to ensure that loci with overlapping size ranges were given different labels. The following reactions were carried out: one triplex reaction with 1.5 pmol of each primer for SCA1 (36) , SCA2 (10) and SCA6 (18) ; a single reaction with 12pmol of each SCA3 primer (SCA3F 5'NED-CTGGCCTTTCACATGG 3' and SCA3R 5' CCA-GTCACTACTTTGATTCGTG 3') and a reaction with 15 pmol of each SCA7 primer (SCA7F 5'VIC-TTGTAGGAGCGGAAAGAAT-GTC 3'and SCA7R 5' CTTCAGGACTGGGCAGAGG 3'). The last two pairs of primers (SCA3 pair and SCA7 pair) were designed for the present study. The triplex reaction was performed with AccuPrime DNA polymerase systems (1X buffer BII -2mM of each dNTPs; 1. o C for 1 hour. Samples were prepared by adding 1 µL of each PCR reaction to 5 µL of deionized formamide and 0.25 µl of internal molecular weight standard (GS-500 ROX). After denaturizing, the samples were injected into an ABI PRISM 3100-Avant Genetic analyzer with a 36 cm × 50 µm capillary containing Performance Optimized Polymer-4 (POP-4) for 5 sec. Amplicon length was calculated by comparison with the molecular weight standard using the Genemapper program.
The sizes of the PCR products were calculated automatically on the basis of a standard curve from the internal size standard. Each allele represents the number of CAG repeats. While different individuals had the same alleles, these differed slightly in size (bp) from the theoretical values for amplicon length of trinucleotide-repeat region. To define the alleles reliably, those individuals with alleles whose sizes were close to the theoretical values were grouped together. Using statistical analysis, the median and variance for clinically normal patients was determined. Those values are used in Genemapper program to determinate the alleles of each loci.
Statistical and genetic analysis
The number of CAG repeats was calculated and statistical analysis performed using SPSS software. Hardy-Weinberg (HW) proportions and heterozygosis (H) were calculated using Genepop software 27, 28 .
RESULTS
The SCA1, SCA2, SCA3, SCA6 and SCA7 loci were analyzed in 308 chromosomes for each locus from 154 normal individuals from Southern Brazil and in 230 chromosomes for each locus from 115 individuals with clinical suspicion of ataxia. The PCR conditions resulted in consistent amplification of the normal-size alleles analyzed, which are seen as well-defined peaks with no background and abnormal expanded are seen with stutter band from somatic mosaicism and technical artifacts (Figs 1 and 2 ).
Inter-assay variability of the same allele among different individuals at each SCA locus (calculated as a 95% confidence interval) ranged from 0.11 to 1.66 bp. For the most frequent alleles at each locus, a higher variance (1.10) was observed in allele 5 of SCA7. The intra-assay variability was taken repeating five times the same product of amplification of five different individuals. This was carried out for the five loci. This variability (calculated as a 95% confidence interval) also was between 0.02 to 0.69 bp.
The allelic frequency for SCA1 locus the allele size ranged from 19 to 36 (CAG)n with 16 different alleles (Table 1). The SCA2 locus allele size ranged from 6 to 28 (CAG)n with 13 different alleles ( Table 2 ). The allele sizes for the SCA3 locus ranged from 12 to 34 (CAG)n with 18 different alleles dispersed through the locus (Table 3 ). In the blood donors, the SCA6 allele size ranged from 2 to 13 (CAG)n with 8 different alleles ( Table 4 ). The SCA7 allele size ranged from 2 to 10 (CAG)n with 7 different alleles ( of the alleles ranged from 14 to 56 (CAG)n and four abnormal expanded alleles were found in six patients (Table 2). The locus SCA3 have the size of the alleles ranging from 12 to 74 (CAG)n with 28 different alleles. There are 11 expanded alleles in 25 patients (Table 3 ). The size between alleles at SCA6 ranged from 2 to 21 (CAG)n with 9 different alleles. Only one expanded allele was found at the SCA6 locus in only one patient (Table 4) . These patients at SCA7 locus showed the size of the alleles ranging from 2 to 50 (CAG)n with two expanded alleles in three patients (Table5). Among the 115 patients with progressive cerebellar ataxia tested, the molecular diagnosis was positive in 35 cases (Table 6 ). The molecular tests confirmed the clinical suspicion in 5 of 7 cases of SCA2, in 20 of 30 cases of SCA3, in 1 of 5 cases of SCA6 and in 2 of 3 SCA7. In the group of unclassified ataxias, was found 1 cases SCA2, 5 cases of SCA3 and 1 case of SCA7 (Table 7) .
At these five subtypes of ataxia, the most frequent among patients is SCA3, followed by SCA2, SCA7 and SCA6. No case of SCA1 was found (Table 8 ).
All individuals with expansion featuring are heterozygous, so they showed a normal allele and the other allele expanded.
No deviations from Hardy-Weinberg (HW) equilibrium were detected and the heterozygosis (H) data for the five loci are in Table 9 . Significant differences in mean allelic size (number base pairs) between patients and control samples were found for SCA2 and SCA3 loci (Table 10) .
DISCUSSION
Capillary electrophoresis (CE) has been used for DNA fragment analysis in a number of studies to determine the number of microsatellite repeats in expansion illnesses [29] [30] [31] . In the present study, small variations in allele size were observed between individuals, although the alleles were close to the expected theoretical sizes. This variation is probably due to factors such as electrophoresis temperature, the polymer batch number, and capillary age [29] [30] [31] . Methods to define alleles in these SCA loci by comparing the results of capillary electrophoresis (CE) with those of PAGE assay have been published and show a discrepancy in amplicons sizes between these methodologies. In CE, amplicons were found to migrate faster than predicted, and the results show a lower number of repeats in one or two peaks [29] [30] [31] . Factors contributing to these discrepancies could be the different sieving effects of cross-linked PAGE compared with the linear polymer used in CE, the electroosmotic effect, the extent of denaturation or differences in secondary structure between amplicons and standard markers 32 . Considering the previous studies regarding differences between PAGE with CE, we did not compare these two methodologies. Since the standard deviation for each allele was small the use of GS-500 ROX provided reliable results. To estimate the range of each allele we analyzed the samples of normal asymptomatic population and defined a pool of existing alleles in these individuals. When the mean allelic size of patients was compared with normal asymptomatic population we found a significant difference in the SCA2 and SCA3 (Table 10) . The 36-repeat allele in the SCA1 locus is borderline in some populations being an intermediate allele with reduced penetrance 8 . Therefore, patients who have this allele should be considered negative for SCA1 in southern Brazilian population. Our data found no intermediate alleles for SCA2, SCA3, SCA6 or SCA7 in the unaffected population. However, studies of families with SCA traits usually reveal an intermediate allele size 3, 8, 10, 33 . Probably, intermediate alleles are as rare as the expanded alleles and it must be found only in affected families with the disease.
A 22-repeat allele is described in other populations as the most frequent at the SCA2 locus 10, 11, 24 . Molecular analysis of unrelated Brazilian families with SCA3 showed that normal alleles ranged from 12 to 33 (CAG)n 34 , and in other populations studied the two major alleles had 14 and 23 (CAG)n 13, 35 . Comparisons of allelic frequencies must be made using population studies based on the CE methodology. Despite the differences in allele size ranges found in this study could be attributed to methodological factors, discrepancies in alleles size ranges are important to characterize the Brazilian population since each human population could present their own genetic profile different from others.
Intermediate allele values tend to trigger the growth of repetitions leading to the expansion. There are studies of clinically normal individuals with MJD in different populations that support the idea that the presence of alleles of size greater than or equal to 27 (CAG)n correlates with higher prevalence of MJD in patients 35 . According to this study we found alleles with a size equal to or greater than 27 (CAG)n in the MJD gene, and MJD is the most frequent ataxia among patients. These findings have an epidemiological interest as these alleles appear to be in haplotypes that have a great potential for expansion by gene conversion 19, [36] [37] [38] [39] [40] . Alleles with a number of (CAG)n greater than 27 are observed in the Portuguese, American, Japanese and African populations, of which there is a high incidence in SCA3 patients 13, 37, 41 . In the patient group in the present study, SCA3 locus had more expanded alleles than other loci. This corroborates the hypothesis that the Portuguese and African populations brought a pool of founding genes to Brazil with a common mutation in the SCA3 gene identified as the cause of MJD (SCA3) 37, [41] [42] [43] . However, other studies of the Portuguese population did not show any correlation between the frequency of the large normal alleles and the frequency of the disease [20] [21] [22] [23] . There was no significant correlation between the frequency of MJD and the frequency of small, medium or large normal alleles in the SCA3 locus of the Portuguese population 23 . Most of the mutant chromosomes worldwide share a common haplotype, and a second haplotype were found to be present in a group of Portuguese patients. Two other additional haplotypes were found in some families. These haplotypes may have derived from a main haplotype as a result of microsatellite mutations 44 . Studies associating intragenic haplotypes with intergenerational repeat length instability in the normal chromosome did not support the hypothesis of pre-mutation 40 . The results of the present study, in which no expanded or intermediate alleles were found in the normal population, corroborate the studies cited above.
Even genetic loci with very similar molecular characteristics have different expansion dynamics. The widespread distribution of the wild-type MJD alleles is attributed to a high mutation rate, without any bias to expansion, which could explain the observed allelic frequencies. This is in accordance with a model that postulates the presence of a small number of mutational events from which most of the MJD cases worldwide have originated 20 and contrasts with findings for Huntington disease (HD) 21 , in which intermediate and expanded alleles are observed in the normal population. The results of these studies may corroborate the idea that there is a mechanism that maintains these diseases in the population and suggest the existence of a few founding chromosomes from which all families originated.
No correlation could be made in the locus SCA 3 only with the data found in this work because patients with MJD is most common form of ataxia and in the sample control no alleles intermediate 46 to 56 (CAG)n) were observed in normal alleles and 2.1% of alleles size range from 27 up to 34 (CAG)n. A study with a larger sample, in which there could be a stratification by Brazilian regions with distinct frequencies of MJD, for example, could lead to a positive or negative correlation between the highest incidence of the disease with normal alleles whose number of (CAG)n are larger than 27. Furthermore, the population study of alleles with potential to expansion can lead to accurate understanding of how alleles are stable avoiding the appearance of alleles expanded. Another interesting fact is that intermediate alleles have ambiguity between the possibility of normal and patient phenotype and is important elucidate possible cis elements involved with molecular mechanisms that may lead to one or the other phenotype.
The present study provides subsidy to understand the origin of the mutations in loci SCA 1, SCA 2, SCA 3, SCA 6 and SCA 7. However, a haplotypic study including other sites of these loci should be carried out in both samples. This is an initial study and in the future other types of ataxia due to CAG repetitions will be done, such as SCA 12, SCA17 and DRPL, to expand the molecular diagnosis at our center.
The unaffected population is in HW equilibrium for the five loci analyzed that demonstrated allelic stabili- ty in this population. Data of heterozygosis (H) characterized the population as the amount heterozygous for each gene. The heterozygosis in this study for the five loci is similar to that that found elsewhere 45 . Heterozygosis similar to the locus ATXN 3 is described in other populations of the world (H=0.84, H=0.86) 37 . This result combined with no deviation of HW equilibrium indicates that the region of (CAG)n in the gene of MJD can be used as a marker in studies of population genetics 23 . The frequency of subtypes of SCA 1, 3 and 6 found in this study is similar to those found in others reports but different for SCA2 and SCA7 34, 45, 46 . The differences between these results may be due to distinct loci analyzed and probably because the sample of Brazilian patients come from different regions of the country. These results are in agreement with the postulations by different authors on the variability of alleles and frequency of subtypes of ataxia in different populations. Furthermore, this difference emphasizes the importance of population study in different regions of Brazil due to the ethnic diversification in the constitution of the country.
In conclusion, the statistical data from our study allowed us to identify the alleles and their frequencies. This study defined the normal range for each one of the five subtypes and found expanded alleles in patients. Population genetic analysis ensured the technical quality of this assay and allowed the normal range of (CAG)n size repeats to be defined in order to distinguish between unaffected and affected individuals for diagnostic purposes. To understand the origins of the mutations at these loci it is important to consider the information provided by the normal range variation so as to understand the dynamics of these loci and provide data to be useful from Southern Brazil.
